Monica M Mckinnon, MD in Medfield, MA - Obstetrics & Gynecology

Monica M Mckinnon, MD is a Obstetrics & Gynecology physician based in Medfield, Massachusetts. Monica M Mckinnon is licensed to practice in Massachusetts (license number 159163) and her current practice location is 35 Farm St, Medfield, Massachusetts. She can be reached at her office (for appointments etc.) via phone at (617) 894-3050.

NPI number for Monica M Mckinnon is 1487612313 and her current mailing address is 35 Farm St, Medfield, Massachusetts. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1487612313.

Contact Information

	Monica M Mckinnon, MD
	35 Farm St, Medfield, MA 02052-1123
	(617) 894-3050
	(888) 600-8612

Physician's Profile

Full Name	Monica M Mckinnon
Gender	Female
Speciality	Obstetrics & Gynecology
Location	35 Farm St, Medfield, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1487612313
Provider Enumeration Date: 05/02/2006
Last Update Date: 08/04/2023

Medical Identifiers

Medical identifiers for Monica M Mckinnon such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1487612313	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207V00000X	Obstetrics & Gynecology	159163 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Monica M Mckinnon is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Monica M Mckinnon, MD 35 Farm St, Medfield, MA 02052-1123 Ph: (617) 894-3050	Monica M Mckinnon, MD 35 Farm St, Medfield, MA 02052-1123 Ph: (617) 894-3050

News Archive

Certain patients with type 2 diabetes, renal impairment discouraged from taking metformin

Many patients with type 2 diabetes in the United States may be discouraged from taking metformin—a proven, oral diabetes medicine—because the U.S. Food and Drug Administration inappropriately labels the drug unsafe for some patients also suffering from kidney problems, researchers from Penn Medicine and Weill Cornel Medical College report this week in a research letter published in JAMA Internal Medicine.

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.

Study: VA hospitals provide better quality care than other health providers

The VA health care system performs similar to or better than non-VA systems on most measures of inpatient and outpatient care quality, although there is high variation in quality across individual VA facilities, according to a new RAND Corporation study.

New preclinical data from Regulus' miR-21 study on kidney fibrosis

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that new preclinical data investigating the role of microRNA-21 (miR-21) in the treatment of kidney fibrosis has been published in the journal Science Translational Medicine.

Monica M Mckinnon, MD - Obstetrics & Gynecology in Medfield, MA